Updates from an FDA panel's review of Aimmune's peanut allergy therapy

Updates from an FDA panel's review of Aimmune's peanut allergy therapy

An FDA advisory panel is reviewing Aimmune’s peanut allergy therapy. Here’s what’s happening

By ADAM FEUERSTEIN

ADOBE

This FDA advisory panel will be a pivotal moment for Aimmune Therapeutics, the biopharma company that developed the new treatment.

READ MORE